KreitchmannR, HarrisDR, KakehasiFet al.Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDs, 2012; 26:486–495.
2.
Transmission PoToH-IPWaPoP. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 2012. http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. 2012 October 30.
3.
VrijensB, De GeestS, HughesDAet al.A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol, 2012; 73:691–705.
4.
KrummenacherI, CavassiniM, BugnonO, SchneiderMP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care, 2011; 23:550–561.
5.
CiambroneD, LoewenthalHG, BazermanLB, ZorillaC, UrbinaB, MittyJA. Adherence among women with HIV infection in Puerto Rico: The potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women. Women Health, 2006; 44:61–77.
6.
NassaliM, NakanjakoD, KyabayinzeD, BeyezaJ, OkothA, MutyabaT. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: Adherence to the postnatal PMTCT program. AIDS Care, 2009; 21:1124–1131.
7.
NachegaJB, UthmanOA, AndersonJet al.Adherence to antiretroviral therapy during and after pregnancy in low-, middle and high income countries: A systematic review and meta-analysis. AIDS, 2012; 26:2039–2052.
8.
MellinsCA, ChuC, MaleeKet al.Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care, 2008; 20:958–968.
9.
IckovicsJR, WilsonTE, RoyceRAet al.Prenatal and postpartum zidovudine adherence among pregnant women with HIV: Results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr, 2002; 30:311–315.
10.
CohnSE, UmblejaT, MrusJ, BardeguezAD, AndersenJW, ChesneyMA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care STDs, 2008; 22:29–40.
11.
NaumovaEN, MustA, LairdNM. Tutorial in Biostatistics: Evaluating the impact of 'critical periods' in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol, 2001; 30:1332–1341.
